Young Li
Stock Analyst at Jefferies
(0.66)
# 4,065
Out of 5,090 analysts
7
Total ratings
50%
Success rate
-15.39%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Initiates: Buy | $145 | $136.51 | +6.22% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $12.63 | -28.74% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $81.40 | +41.28% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.08 | +15.74% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $27.02 | +122.06% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $9.60 | +379.17% | 1 | Jul 16, 2021 |
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $136.51
Upside: +6.22%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $12.63
Upside: -28.74%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $81.40
Upside: +41.28%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.08
Upside: +15.74%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $27.02
Upside: +122.06%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $9.60
Upside: +379.17%